Clinical Trial Update: Safety and Efficacy of Meplazumab in Patients With Coronary Artery Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the safety and efficacy of meplazumab in patients with coronary artery disease is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Meplazumab (meplazumab)

Snippet

Sponsor: Xijing Hospital | Conditions: Coronary Artery Disease | Phase 2 | Status: RECRUITING